Fluphenazine-resistant Saccharomyces cerevisiae mutants defective in the cell division cycle

Journal of Bacteriology
|December 1, 1986
PubMed

Insights

Researchers isolated a Saccharomyces cerevisiae fls1 mutant and developed fluphenazine-resistant mutants. These mutants, fsr1 and fsr2, revealed cell cycle arrest points, offering insights into yeast genetics and drug resistance mechanisms.

Area of Science:

  • * Molecular biology
  • * Yeast genetics
  • * Cell cycle regulation

Background:

  • * Fluphenazine is a drug that can inhibit growth in certain yeast mutants.
  • * Understanding drug resistance mechanisms in Saccharomyces cerevisiae is crucial for genetic studies.

Purpose of the Study:

  • * To isolate and characterize novel fluphenazine-resistant mutants in Saccharomyces cerevisiae.
  • * To investigate the genetic basis of fluphenazine resistance and its effect on cell cycle progression.

Main Methods:

  • * Isolation of fluphenazine-sensitive (fls1) mutants in Saccharomyces cerevisiae.
  • * Induction of resistance and temperature sensitivity in fls1 mutants.
  • * Genetic mapping of resistance mutations (fsr1) and phenotypic analysis of mutants (fsr2).

Main Results:

  • * Isolation of an fls1 mutant sensitive to fluphenazine.
  • * Identification of two distinct fluphenazine-resistance mutations: fsr1 and fsr2.
  • * fsr1 mutants exhibited cell cycle arrest post-nuclear division at elevated temperatures.
  • * fsr2 mutants displayed calcium-dependent growth and G2 stage cell cycle arrest in calcium-poor conditions.

Conclusions:

  • * The fsr1 mutation is linked to chromosome II and affects post-nuclear division.
  • * The fsr2 mutation confers calcium-dependent growth and impacts the G2 stage of the cell cycle.
  • * These findings contribute to understanding yeast cell cycle control and fluphenazine resistance mechanisms.

Related Concept Videos